A new clinical trial to investigate the use of artificial pancreas system is set to begin, bringing in touchscreen insulin pump maker Tandem Diabetes Care; Dexcom, which makes continuous glucose ...
Goldman Sachs initiated coverage on Insulet Corporation (NASDAQ:PODD), citing the company to benefit from accelerating the adoption of patch pump technology as it is the only participant in the ...
SAN DIEGO--(BUSINESS WIRE)--Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the United States commercial launch of its new Tandem ...
– Additional data presented at the 18th International Conference on Advanced Technologies & Treatments for Diabetes – Results published in NEJM demonstrate significant improvements in time in range ...
The company has integrated its Eversense 365 implant with Sequel Med Tech’s insulin delivery system to automate the management of Type 1 diabetes.
AdvaMed said Monday that new Dexcom CEO Jake Leach will lead the diabetes sector for the medtech lobbying group. AdvaMed’s diabetes sector represents several diabetes technology companies, including ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results